Mirena 52 MG systems
Ended Awarded
- Contract number
- SPE2DB25FEQCE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,166
Award facts
- Contract value 100% obligated
- $4,166.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,166.24 by the Defense Logistics Agency (DLA) on August 4, 2025, for Mirena 52 mg systems. The delivery order, which carries no set-aside designation, is scheduled for completion by August 25, 2025, with performance taking place in Park Ridge, Illinois. This award represents a discrete delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.9 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities nationwide.
Mirena systems are hormonal intrauterine devices used for contraception and treatment of heavy menstrual bleeding, reflecting the breadth of pharmaceutical products DMS Pharmaceutical Group supplies to federal healthcare systems. The company's established position as a critical supplier in the federal pharmaceutical supply chain demonstrates the DLA's reliance on its capabilities to deliver specialized medical devices and pharmaceuticals. DMS Pharmaceutical Group's consistent success in competing for federal pharmaceutical contracts, combined with its woman-owned small business status and longstanding registration in SAM.gov since 2001, positions it as a trusted vendor for supporting Department of Defense healthcare requirements.
Quick answers
Who was awarded contract SPE2DB25FEQCE?
SPE2DB25FEQCE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FEQCE worth?
The government has obligated $4,166 on SPE2DB25FEQCE.
Is contract SPE2DB25FEQCE an order under another contract?
Yes. SPE2DB25FEQCE is a delivery order under SPE2DB24D9113, an indefinite delivery contract.
Was contract SPE2DB25FEQCE competed?
The extent of competition for SPE2DB25FEQCE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award